GJB5

Last update 08 May 2025

Basic Info

Synonyms

connexin 31.1, Connexin-31.1, CX31.1

+ [6]

Introduction

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.

100 Clinical Results associated with GJB5

100 Translational Medicine associated with GJB5

0 Patents (Medical) associated with GJB5

Literatures (Medical) associated with GJB5

01 Dec 2024·Cell and Tissue Research

Regulation of the gap junction interplay during postnatal development in the rat epididymis

Article

Author: Dufresne, Julie ; Gregory, Mary ; Cyr, Daniel G. ; Adam, Cécile ; Cyr, Daniel G

During postnatal development of the rat epididymis, a change in the expression of gap junction proteins, or connexins (Cxs), occurs, in which Gjb2 (Cx26) and Gja1 (Cx43) levels in the proximal epididymis are decreased, while Gjb1 (Cx32), Gjb4 (Cx30.3) and Gjb5 (Cx31.1) levels increase. The mechanism(s) responsible for the switch in Cx expression is unknown. The aim of this study is to identify the mechanisms responsible for the decrease in GJB2 protein levels and the increase in other Cxs during postnatal development. Results indicate that decreased Gjb2 expression for 48 h does not alter the expression of other Cxs in RCE-1 principal cells, suggesting a lack of compensatory expression. Sequence analysis of both Gjb2 and Gjb1 promoters identified common multiple response elements to steroid hormones. Using RCE-1 cells, we observed that dexamethasone increased Gjb2 mRNA levels by twofold after 48 h, while estradiol had no effect. Orchidectomy in rats resulted in a significant increase in GJB2 and decreased GJB1 in the caput and corpus epididymidis. Changes in Cxs protein levels were prevented by testosterone in orchidectomized rats. Similar results were observed in the prostate, another androgen-receptive organ. LNCaP cells, which are androgen-responsive, showed that exogenous dihydrotestosterone (DHT) decreased Gjb2 mRNA levels by approximately 50% concomitant with a 1.5-fold increase in Gjb1 levels. Using a GJB1 promoter construct we showed that DHT could induce transactivation of the luciferase transgene, while transactivation of two GJB2 promoters were unaltered. Results indicate that androgens and glucocorticoids regulate the expression of epididymal Cxs.

03 Apr 2024·Current Medicinal Chemistry

Identification and Functional Characterization of Essential Genes Related to Gefitinib Sensitivity in Lung Adenocarcinoma

Article

Author: Wang, Rui ; Zhang, Lu

Aims:This study aimed to determine the molecular markers related to gefitinib sensitivity for guiding the prognosis of lung adenocarcinoma (LUAD) and providing new evidence for promoting the precise treatment of LUAD.background:The World Health Organization stressed the need for molecular markers as diagnostic criteria for lung cancer in 2015 and 2021.Background:Lung adenocarcinoma (LUAD) is a prevalent lung cancer subtype with inferior survival outcomes. However, gefitinib is the first molecular targeted drug approved by Food and Drug Administration (FDA) to treat advanced LUAD. Gefitinib sensitivity-related gene targets for LUAD are rarely studied.objective:This study was designed to determine the potential molecular markers related to the sensitivity of Gefitinib in lung adenocarcinoma (LUAD), and to study their relationship with tumor biological traits.Objective:This study was designed to probe the potential molecular markers related to the sensitivity of gefitinib in LUAD.Methods:The gene expression profiles of LUAD cells in the Genomics of Drug Sensitivity in Cancer (GDSC) database were used for Weighted Gene Co-expression Network Analysis (WGCNA) to select the modules most related to gefitinib sensitivity. The Cancer Genome Atlas (TCGA) database was used to compare the expression of LUAD and para-cancerous tissues. Differentially expressed genes (DEGs) were then filtered and intersected with the highly linked genes in the module relevant to gefitinib sensitivity. Univariate Cox regression analysis was conducted to identify prognostically related genes to LUAD. The correlation between genes and drug IC50 was calculated by Spearman correlation analysis. Quantitative RT-PCR and immunofluorescence detection validated hub genes FAM13B and PFKP expressions.Results:Among the 10 modules divided by WGCNA, the module with the most significant positive correlation and the most significant negative correlation with gefitinib sensitivity were found. FAM13B, PFKP, FGD3, RNASE1, MUC16, GJB5, and GJB3 were hub genes related to gefitinib sensitivity in LUAD. Significantly, the low expressed FAM13 in LUAD tissues positively correlated with immune response. At the same time, overexpressed PFKP in the LUAD cohort was related to an unfavorable prognosis, cell proliferation, and cell cycle. We also found that FAM13B and PFKP expressions were enhanced in LUAD cell lines.Conclusions:This study identified 7 critical genes related to gefitinib sensitivity in LUAD. Functionally, genes positively correlated with gefitinib sensitivity might regulate the progression of LUAD through the immune, cell cycle, and metabolic pathways and showed potential effects in predicting sensitivity to different drugs. These findings help offer a theoretical direction for personalized treatment of LUAD.

01 Apr 2024·Journal of Cell Science

Cx31.1 can selectively intermix with co-expressed connexins to facilitate its assembly into gap junctions

Article

Author: Lucaciu, Sergiu A. ; Bai, Donglin ; Penuela, Silvia ; Wong, Robert S. ; Hauser, Alexandra ; Stathopulos, Peter B. ; Leighton, Stephanie E. ; Johnston, Danielle ; Laird, Dale W.

ABSTRACTConnexins are channel-forming proteins that function to facilitate gap junctional intercellular communication. Here, we use dual cell voltage clamp and dye transfer studies to corroborate past findings showing that Cx31.1 (encoded by GJB5) is defective in gap junction channel formation, illustrating that Cx31.1 alone does not form functional gap junction channels in connexin-deficient mammalian cells. Rather Cx31.1 transiently localizes to the secretory pathway with a subpopulation reaching the cell surface, which is rarely seen in puncta reminiscent of gap junctions. Intracellular retained Cx31.1 was subject to degradation as Cx31.1 accumulated in the presence of proteasomal inhibition, had a faster turnover when Cx43 was present and ultimately reached lysosomes. Although intracellularly retained Cx31.1 was found to interact with Cx43, this interaction did not rescue its delivery to the cell surface. Conversely, the co-expression of Cx31 dramatically rescued the assembly of Cx31.1 into gap junctions where gap junction-mediated dye transfer was enhanced. Collectively, our results indicate that the localization and functional status of Cx31.1 is altered through selective interplay with co-expressed connexins, perhaps suggesting Cx31.1 is a key regulator of intercellular signaling in keratinocytes.

Analysis

Perform a panoramic analysis of this field.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis